Literature DB >> 27373606

Spectrum of Alcoholic Liver Disease.

Kristina Rachel Chacko1, John Reinus2.   

Abstract

Liver disease from excessive alcohol consumption is an important cause of morbidity and mortality worldwide. There is a clear relationship between alcohol and a variety of health and socioeconomic problems. According to the World Health Organization, 3.3 million people die of alcohol-related causes annually. Despite public knowledge of its potential adverse effects, alcohol consumption and the morbidity and mortality from alcoholic liver disease (ALD) have increased. ALD comprises a spectrum of injury, including simple steatosis, acute alcoholic hepatitis, and cirrhosis. Rather than being distinct disease entities, these pathologic processes frequently overlap.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcoholic hepatitis; Alcoholic liver disease; Epidemiology of alcohol abuse; Risk factors for alcoholic liver disease

Mesh:

Year:  2016        PMID: 27373606     DOI: 10.1016/j.cld.2016.02.002

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  16 in total

1.  Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis.

Authors:  Katharina Brandl; Phillipp Hartmann; Lily J Jih; Donald P Pizzo; Josepmaria Argemi; Meritxell Ventura-Cots; Sally Coulter; Christopher Liddle; Lei Ling; Stephen J Rossi; Alex M DePaoli; Rohit Loomba; Wajahat Z Mehal; Derrick E Fouts; Michael R Lucey; Francisco Bosques-Padilla; Philippe Mathurin; Alexander Louvet; Guadalupe Garcia-Tsao; Elizabeth C Verna; Juan G Abraldes; Robert S Brown; Victor Vargas; Jose Altamirano; Juan Caballería; Debbie Shawcross; Peter Stärkel; Samuel B Ho; Ramon Bataller; Bernd Schnabl
Journal:  J Hepatol       Date:  2018-04-12       Impact factor: 25.083

Review 2.  A Unifying Hypothesis Linking Hepatic Adaptations for Ethanol Metabolism to the Proinflammatory and Profibrotic Events of Alcoholic Liver Disease.

Authors:  Zhi Zhong; John J Lemasters
Journal:  Alcohol Clin Exp Res       Date:  2018-09-17       Impact factor: 3.455

3.  MicroRNA-200a induces apoptosis by targeting ZEB2 in alcoholic liver disease.

Authors:  Yu-Xin Zhao; Ying-Yin Sun; Ai-Ling Huang; Xiao-Feng Li; Cheng Huang; Tao-Tao Ma; Jun Li
Journal:  Cell Cycle       Date:  2018-01-15       Impact factor: 4.534

4.  Regulation of Cytochrome P450 2B10 (CYP2B10) Expression in Liver by Peroxisome Proliferator-activated Receptor-β/δ Modulation of SP1 Promoter Occupancy.

Authors:  Takayuki Koga; Pei-Li Yao; Maryam Goudarzi; Iain A Murray; Gayathri Balandaram; Frank J Gonzalez; Gary H Perdew; Albert J Fornace; Jeffrey M Peters
Journal:  J Biol Chem       Date:  2016-10-20       Impact factor: 5.157

5.  Colesevelam Reduces Ethanol-Induced Liver Steatosis in Humanized Gnotobiotic Mice.

Authors:  Noemí Cabré; Yi Duan; Cristina Llorente; Mary Conrad; Patrick Stern; Dennis Yamashita; Bernd Schnabl
Journal:  Cells       Date:  2021-06-14       Impact factor: 7.666

6.  Acute Isolated Hyperbilirubinemia as a Presentation of Alcoholic Liver Disease: A Case Report and Literature Review.

Authors:  Muhammad Rajib Hossain; Ramesh Kumar Pandey; Mohammad Faridul Islam; Praveen Datar; Vijay Gayam; Pradeep Puri; Thwin Malar
Journal:  Case Reports Hepatol       Date:  2018-02-12

7.  FXR and TGR5 Agonists Ameliorate Liver Injury, Steatosis, and Inflammation After Binge or Prolonged Alcohol Feeding in Mice.

Authors:  Arvin Iracheta-Vellve; Charles D Calenda; Jan Petrasek; Aditya Ambade; Karen Kodys; Luciano Adorini; Gyongyi Szabo
Journal:  Hepatol Commun       Date:  2018-10-15

Review 8.  Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives.

Authors:  Szu-Yi Liu; I-Ting Tsai; Yin-Chou Hsu
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

9.  MiR-30e-UCP2 pathway regulates alcoholic hepatitis progress by influencing ATP and hydrogen peroxide expression.

Authors:  Xi Jin; Mo-Sang Yu; Yue Huang; Zun Xiang; Yi-Peng Chen
Journal:  Oncotarget       Date:  2017-07-31

10.  Fatty liver index as a predictor of increased risk of cardiometabolic disease: finding from the Kuopio Ischaemic Heart Disease Risk Factor Study Cohort.

Authors:  Olubunmi O Olubamwo; Jyrki K Virtanen; Jussi Pihlajamaki; Pekka Mantyselka; Tomi-Pekka Tuomainen
Journal:  BMJ Open       Date:  2019-09-05       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.